Amino Asylum FDA raid
This is one entry from the TitrateLab Vendor Graveyard, a dated, primary-source archive of peptide-market shutdowns, exit scams, and enforcement actions. Documented as June 18, 2025 (approximate). Sources for this entry are named inline below and numbered in full on the parent archive page.
The first physical federal raid on a major e-commerce peptide vendor.
Federal authorities raided Amino Asylum’s Memphis warehouse on or around June 18, 2025. The website went offline overnight. Payment processing was terminated. Pending orders were frozen with no refund mechanism announced. Amino Asylum had been one of the top-five most-searched peptide vendors, with an estimated 400,000+ monthly website visitors.
The raid targeted products labeled as SARMs that in fact contained testosterone, a Schedule III controlled substance under the Anabolic Steroid Control Act. That mislabeling elevated the case from FDA-civil-enforcement (unapproved new drugs) to DEA-adjacent controlled-substance territory, which is why the physical raid and rapid DOJ plea followed.
Why it still matters: industry-shaping. Before June 2025, the e-commerce grey market operated on the assumption that FDA enforcement meant warning letters, not warrants. After June 2025, the market priced in physical raid risk. Within weeks, peer vendors began pre-emptive catalog trimming, customer migration to Peptide Sciences accelerated (ironically, the next to fall), and the “it can happen to any of us” sentiment became the baseline.
Primary sources: MuscleAndBrawn retrospective; PSPeptides retrospective; contemporaneous Evolutionary.org forum thread; PeptideExaminer vendor dossier.